Mass screening for breast cancer: Benefits, risks, costs Jack ValentinWolfram Leitz Original Articles Pages: 77 - 83
Interleukin 2 activity in peripheral blood mononuclear cells of patients with gynecologic malignancies Yoshihiro KikuchiTsunekazu KitaIsao Kizawa Original Articles Pages: 85 - 90
Differentiation of human leukaemic cell lines and fresh leukaemia cells by low dose Ara-C: Monitoring by expression ofc-myc andc-fos oncogenes Antonio PintoVincenza AttadiaAlfonso Colombatti Original Articles Pages: 91 - 97
Luminol-enhanced chemiluminescence of peripheral blood leukocytes as an early indicator of graft take after allogeneic bone marrow transplantation in patients with acute myelogenous leukaemia Allan RajamäkiEsa-Matti LiliusAuli Toivanen Original Articles Pages: 99 - 102
Double-blind, placebo-controlled lithium treatment in chemotherapy induced aplasia for AML: Reduced antibiotic requirement Santiago ColladoDominique CharronLaurent Degos Original Articles Pages: 103 - 105
Effect of cytostatics on liver retinol store in rat Karl-Olaf WathneRune BlomhoffKaare R. Norum Original Articles Pages: 107 - 112
Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracil Michael C. WiemannGerald W. CrabtreePaul Calabresi Original Articles Pages: 113 - 116
The pharmacokinetics of high dose cyclophosphamide and high dose etoposide D. CunninghamJ. CummingsM. Soukop Original Articles Pages: 117 - 123
Adriamycin, vincristine and mitomycin C as first and second line therapy for advanced breast carcinoma M. HardingG. SangsterK. C. Calman Original Articles Pages: 125 - 128
Diazepam ablates the constitutional side-effects of gamma interferon Gerald J. BeattieJohn F. Smyth Case Report Pages: 129 - 130
Pharmacokinetics of epirubicin in man. Non-influence of alpha interferon Staffan EksborgKarin Mattson Short Report Pages: 131 - 133
A cytostatic drug (taxol) which does not inhibit monocyte phagocytosis Leif AthlinLennart DomellöfBo Norberg Short Report Pages: 135 - 138
